November 8, 2010

Athersys Announces FDA Authorization of Phase II Clinical Trial for Inflammatory Bowel Disease With Pfizer Regenerative Medicine

This press release is no longer available. To view all releases, visit our Press Releases page.


Close window | Back to top

Copyright 2017 Athersys